"Hypnotics and Sedatives" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
| Descriptor ID |
D006993
|
| MeSH Number(s) |
D27.505.696.277.350 D27.505.954.427.210.350
|
| Concept/Terms |
Hypnotic Effect- Hypnotic Effect
- Effect, Hypnotic
- Hypnotic Effects
- Effects, Hypnotic
Sedative Effect- Sedative Effect
- Effect, Sedative
- Sedative Effects
- Effects, Sedative
|
Below are MeSH descriptors whose meaning is more general than "Hypnotics and Sedatives".
Below are MeSH descriptors whose meaning is more specific than "Hypnotics and Sedatives".
This graph shows the total number of publications written about "Hypnotics and Sedatives" by people in this website by year, and whether "Hypnotics and Sedatives" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypnotics and Sedatives" by people in Profiles.
-
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA. 2022 07 12; 328(2):213-214.
-
Favorable Outcomes After Implementing a Nurse-Driven Sedation Protocol. Crit Care Nurse. 2021 Dec 01; 41(6):29-35.
-
Dexmedetomidine in critically ill adults requiring noninvasive ventilation. Acad Emerg Med. 2022 Mar; 29(3):384-386.
-
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021 03; 9(3):239-250.
-
Drugs Used in Circadian Sleep-Wake Rhythm Disturbances. Sleep Med Clin. 2018 Jun; 13(2):231-241.
-
Polypharmacological in Silico Bioactivity Profiling and Experimental Validation Uncovers Sedative-Hypnotic Effects of Approved and Experimental Drugs in Rat. ACS Chem Biol. 2017 06 16; 12(6):1593-1602.
-
The relationship between the Bispectral Index (BIS) and the Observer Alertness of Sedation Scale (OASS) scores during propofol sedation with and without ketamine: a randomized, double blinded, placebo controlled clinical trial. J Clin Monit Comput. 2016 Aug; 30(4):495-501.
-
The effect of ketamine on hypoventilation during deep sedation with midazolam and propofol: a randomised, double-blind, placebo-controlled trial. Eur J Anaesthesiol. 2014 Dec; 31(12):654-62.
-
Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
-
Treatment of delirium following cardiac surgery. J Card Surg. 2012 Sep; 27(5):589-93.